Recent inventions on receptor tyrosine kinase RET modulation

Area of Science:

• Molecular Biology
• Neuroscience
• Oncology

Background:

• Rearranged during transfection (RET) is a receptor tyrosine kinase vital for neural crest cell development.
• RET activation, mediated by Glial cell-derived neurotrophic factor (GDNF)-family ligands (GFLs) and receptors (GFRs), regulates cell survival, growth, differentiation, and migration.
• Dysregulation of RET signaling is linked to cancers (e.g., medullary thyroid carcinoma) and developmental disorders (e.g., Hirschsprung disease).

Purpose of the Study:

• To review recent international patents concerning the modulation of RET kinase activity.
• To explore the therapeutic potential of targeting RET signaling pathways.
• To highlight the development of small-molecule and peptide-based agonists and antagonists for RET modulation.

Main Methods:

• Literature review of international patent filings related to RET kinase modulators.
• Analysis of patented compounds targeting the RET signaling pathway.
• Synthesis of information on small-molecule and peptide-based therapeutic strategies.

Main Results:

• Identification of numerous patents focused on small-molecule and peptide-based RET modulators.
• Demonstration of diverse approaches to target RET for therapeutic intervention.
• Highlighting the growing interest in RET as a pharmaceutical target.

Conclusions:

• RET kinase activity modulation holds significant therapeutic promise for various diseases.
• Patented agonists and antagonists offer potential treatments for RET-associated cancers and neurodegenerative conditions.
• Further research and development of RET-targeting agents are warranted.